��ɫ��Ӱ

"Companies developing Covid-19 treatments run the risk of acting too quickly," warns SIEPR Senior Fellow Anat Admati, professor of finance and economics at the ��ɫ��Ӱ GSB.

“The challenge is to manage [conflicts of interest involving scientific experts] appropriately [...]," says SIEPR Senior Fellow Joseph Grundfest.

"As countries around the world ponder strategies for developing a COVID-19 vaccine, it should be clear that the fastest and most effective approach is to work together." [...]

Susan Athey, Christopher Snyder, Nobel prize winner Michael Kremer, & Alex Tabarrok advocate for a large advance market commitment to accelerate investment in COVID-19 vaccine[...]

SIEPR Senior Fellow Michael Boskin discusses several ways to reduce the health risks associated with a gradual return to normal economic activity.

Dr. Jay Bhattacharya discusses how ��ɫ��Ӱ is testing for coronavirus antibodies in order to determine who has been exposed and who could potentially go back to school or work.

A new initiative has been launched to urge universities and companies to free up intellectual property (IP) to spur development of treatments and cures for Covid-19.

"Speeding the development of vaccines and effective drug therapies by vastly increasing the rewards for businesses would decisively limit the economic damage," says Hanno Lustig.

“People will change their habits, and some of these habits will stick,” said SIEPR Senior Fellow Susan Athey [...]

Sr Fellow Ran Abramitzky discusses his research showing new immigrants to the United States assimilate as quickly as they ever did, and delves into what that means for the economy.

A two-year study by SIEPR Senior Fellow Nicholas Bloom found that telecommuting resulted in remarkable productivity gains—but there are even more potential benefits, beyond that.

According to SIEPR Sr Fellow David Lobell of ��ɫ��Ӱ’s Center on Food Security & the Environment, dry tropical regions are vulnerable to the worst impacts of climate change [...]

SIEPR Senior Fellow Pete Klenow discusses how population growth, trade, Big Tech, and innovations might affect America’s capacity for economic growth.